Journal profile · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Nuclear Medicine Review
ISSN 1506-9680 · eISSN 1644-4345 · Via Medica · Poland
Nuclear Medicine Review: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; median 54 days to acceptance (36 articles, last 24 months); 26 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Nuclear Medicine Review is published by Via Medica and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Medical Imaging and Pathology Studies, together about 37.8% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Nuclear Medicine Review (NMR) is an open access, peer-reviewed journal publishing papers which report original clinical and experimental research contributing to the advancement of knowledge in the field of nuclear medicine. The Journal also accepts review papers, clinical vignettes, letters and book reviews. Editors include editorials and also news on congresses and symposia.
From the journal's Aims & Scope
Research area (LetPub): RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Editor-in-chief Grzegorz KamińskiPublisher website
Editorial board by country: none in mainland China; most named Poland 25, Italy 6, Czechia 4, Serbia 4, Germany 3 (59 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine16.7%
- Radiopharmaceutical Chemistry and ApplicationsMedicine11.6%
- Medical Imaging and Pathology StudiesMedicine9.5%
- Cardiac Imaging and DiagnosticsMedicine7.9%
- Thyroid Cancer Diagnosis and TreatmentMedicine6.1%
- Neuroendocrine Tumor Research AdvancesMedicine5.2%
- Radiation Dose and ImagingMedicine4.3%
- Thyroid and Parathyroid SurgeryMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePublisher website
Other: EBSCO, ProQuest, CNKI, Crossref, Arianta, CNKI (China National Knowledge Index), Index Copernicus, Polish Medical Library (GBL), Polish Ministry of Science and Higher Education, Polish Scientific Bibliography (PBN), Polindex, ROAD (Directory of Open Access Scholarly Resources), SJR (Scimago Journal & Country Rank), Ulrich's Periodicals Directory
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.4LetPub ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 82OpenAlex ·
- 2-year mean citedness
- 0.38OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 98.33%LetPub ·
Volume
- Articles per year
- 20LetPub ·
Articles by year OpenAlex count · 430 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 16 | 16 | 0 |
| 2025 | 26 | 26 | 4 |
| 2024 | 14 | 14 | 17 |
| 2023 | 22 | 22 | 60 |
| 2022 | 41 | 41 | 106 |
| 2021 | 30 | 30 | 127 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
54 daysMedian, submission to acceptance · P25–P75 30 days – 86 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 36 articles with submission and acceptance dates (38 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 24 weeksLetPub ·
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Cover letter
- Required
Article types accepted1
- reviewTitle page, Abstract and keywords, Introduction, Main text divided into subheadings, Conclusions, Acknowledgements, Statement of competing interests, List of ab…Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review
- License & copyright Copyright Notice
All articles published by “Nuclear Medicine Review” become a property of the Publisher. Reprints of both whole articles and extracts, as well as translations to other languages for commercial use can be produced only after obtaining relevant permission from the Publisher. Copyright transfer Sending the manuscript the author(s) confirm(s) that (s)he has (they have) not previously submitted it to an…
Source ↗Publisher website ·- Open access Open Access Policy
Articles published on-line in the Journal are available in open access immediately after publication and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercia…
Source ↗Publisher website ·- Peer review Peer Review Process
Follows ICMJE editorial recommendations Model summary
The Journal is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files (if applicable) should be submitted online via the journal web page. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation directions presented below. Manuscript…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Via Medica
- Country or region
- Poland
- Language
- English
- ISSN
- 1506-9680
- Electronic ISSN
- 1644-4345
- Latest issue on the website
- Volume 29 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Nuclear Medicine Review
What CAS zone is Nuclear Medicine Review in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nuclear Medicine Review is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Nuclear Medicine Review?
Based on the dates recorded on 36 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 54 days (interquartile range 30–86 days); authors report an average review time of about 24 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Nuclear Medicine Review based?
Of the 59 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (25), Italy (6) and Czechia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Nuclear Medicine Review?
According to LetPub and DOAJ records, Nuclear Medicine Review is indexed in ESCI, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is Nuclear Medicine Review open access, and what is the APC?
Nuclear Medicine Review is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .